November 16, 20220CommentsZombie Stock #21 – Don’t Join This TeamThis company will need either a capital raise or a significant change in business operations soon to remain a going concern. by Matt Shuler, Investment Analyst II
November 11, 20220CommentsICYMI: Updated Long Idea, 2 Danger Zone Updates, New Live Webinars, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Matt Shuler, Investment Analyst II
November 11, 20220CommentsFeatured Stocks in November’s Most Attractive/Most Dangerous Model PortfoliosSee two of the featured stocks from this month’s Most Attractive and Most Dangerous Stocks model portfolios. by Matt Shuler, Investment Analyst II
November 10, 20220CommentsMake a Claim on These Cash FlowsDespite large increases in the cost of claims in 2022, this stock still offers favorable risk/reward to investors in the long term. by Matt Shuler, Investment Analyst II
November 4, 20220CommentsICYMI: 2 Long Ideas, a Dangerous Mutual Fund, New Live Webinars, #1-Ranked Stock Picker Again, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Matt Shuler, Investment Analyst II
November 4, 20220CommentsFeatured Stock in October’s Dividend Growth Model PortfolioFive new stocks made October's Dividend Growth Stocks Model Portfolio this month. Get a free look at one of the stocks in this month’s portfolio. by Matt Shuler, Investment Analyst II
November 2, 20221CommentsA Strong Foundation for Future Profit GrowthThis company is positioned for long-term profit growth and its stock still offers attractive risk/reward. by Matt Shuler, Investment Analyst II
November 2, 20220CommentsSuperior Profitability Will Lift this Stock HigherThis stock still offers investors plenty of upside after successfully navigating the pandemic turbulence. by Matt Shuler, Investment Analyst II
October 28, 20220CommentsICYMI: New Daily/Weekly Webinars, Mobileye’s Overvalued IPO, Model Portfolio Update, 4Q22 Style Ratings, and the Best & Worst ETFs & Mutual Funds in 4Q22Here's what happened at New Constructs this past week. by Matt Shuler, Investment Analyst II
October 28, 20220CommentsFeatured Stock in October’s Safest Dividend Yields Model PortfolioGet a look at the featured Stock from October's Safest Dividend Yields Model Portfolio, which leverages our proven-superior research. by Matt Shuler, Investment Analyst II
October 25, 20220CommentsNo Automated Profits in Mobileye’s IPOGiven increased competition, a history of unprofitability, and an undifferentiated product offering, there are no automated profits in this IPO. by Matt Shuler, Investment Analyst II
October 21, 20220CommentsICYMI: New Long Idea, Zombie Stock #19, Banker Hail Mary, Barron’s Features Our Tesla Research, 4Q22 Style Ratings, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Matt Shuler, Investment Analyst II
October 20, 20220CommentsFeatured Stock in October’s Exec Comp & ROIC Model PortfolioFeatured stock from October's Exec Comp Aligned with ROIC Model Portfolio which leverages our proven-superior research. by Matt Shuler, Investment Analyst II
October 19, 20220CommentsSteady Income in a Volatile MarketOur forward-looking research found an ETF filled with companies that generate steady cash flows and have undervalued stock prices. by Matt Shuler, Investment Analyst II
October 14, 20220CommentsHow This Stock’s Outrageous Valuation Could Destroy All Zombie StocksThis stock is a bellwether that could destroy all zombie stocks. by Matt Shuler, Investment Analyst II
October 14, 20220CommentsICYMI: New Long Idea, TSLA Could Take Down All Zombie Stocks, Fortune Features Zombie Picks, Wealthion: Systemic Threats to the Market, 4Q22 Sector Ratings, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Matt Shuler, Investment Analyst II
October 14, 20220CommentsFeatured Stocks in October’s Most Attractive/Most Dangerous Model PortfoliosSee two of the featured stocks from this month’s Most Attractive and Most Dangerous Stocks model portfolios. by Matt Shuler, Investment Analyst II
October 12, 20221CommentsThe Building Block for a Healthy ReturnA strong balance sheet and lasting demand for this company's products position it for long-term profit growth. by Matt Shuler, Investment Analyst II
October 7, 20220CommentsICYMI: Companies Most Likely to Beat & Miss 3Q22 Earnings, Zombie Stock #18, Focus List Stocks Outperform Through 3Q22, #1-Ranked Stock Picker Again, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Matt Shuler, Investment Analyst II
October 7, 20220CommentsFeatured Stock in September’s Dividend Growth Model PortfolioSeven new stocks made September's Dividend Growth Stocks Model Portfolio this month. Get a free look at one of the stocks in this month’s portfolio. by Matt Shuler, Investment Analyst II